Skip to main content Accessibility help
×
Home

Treatment-resistant depression: a challenge for future research

  • Siegfried Kasper (a1)
  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Treatment-resistant depression: a challenge for future research
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Treatment-resistant depression: a challenge for future research
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Treatment-resistant depression: a challenge for future research
      Available formats
      ×

Abstract

Copyright

References

Hide All
1.Fawcett, J, Kravitz, HM. Treatment refractory depression. In: Schatzberg AF, editor. Common treatment problems in depression. Washington, DC: American Psychiatric Press, 1985, 127.
2.Schosser, A, Serretti, A, Souery, Det al. European Group for the Study of Resistant Depression (GSRD) – where have we gone so far: review of clinical and genetic findings. Eur Neuropsychopharmcol 2012a; 22:453468.
3.Konstantinidis, A, Papageorgiou, K, Grohmann, Ret al. Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: Results from the AMSP International Pharmacovigilance Program. Int J Neuropsychopharmacol 2012;15:449457.
4.Souery, D, Oswald, P, Massat, Iet al. Clinical factors associated with treatment resistance in major depression: results from a European multicenter study. J Clin Psychiatry 2007;68:10621070.
5.Mendlewicz, J, Massat, I, Linotte, Set al. Identification of clinical factors associated with resistance to antidepressants in bipolar depression. Results from a European multicentre study. Int Clin Psychopharmacol 2010;25:297301.
6.Souery, D, Serretti, A, Calati, Aet al. Citalopram versus desipramine in treatment resistant depression: effect of continuation or switching strategies: a randomized open study. World J Biol Psychiatry 2011;12:364375.
7.Papakostas, GI, Fava, M, Thase, ME. Treatment of SSRI-resistant depression: a meta-analysis comparing within- versus across-class switches. Biol Psychiatry 2008;63:699704.
8.Kasper, S, Montgomery, S. Treatment-resistant depression. Chichester: Wiley-Blackwell, 2013.
9.Serretti, A, Calati, R, Massat, Iet al. Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients. Int Clin Psychopharmacol 2009;24:250256.
10.Kocabas, NA, Faghel, C, Barreto, Met al. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study. Int Clin Psychopharmacol 2010;25:218227.
11.Massat, I, Kocabas, NA, Crisafulli, Cet al. COMT and age at onset in mood disorders: a replication and extension study. Neurosci Lett 2011;498:218221.
12.Schosser, A, Calati, R, Serretti, Aet al. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder – A European multicenter study. Eur Neuropsychopharmacol 2012b;22:259266.
13.Schosser, A, Kasper, S. The role of pharmacogenetics in the treatment of depression and anxiety disorders. Int Clin Psychopharmacol 2009;24:277288.
14.Serretti, A, Fabbri, C. Shared genetics among major psychiatric disorders. Lancet 2013;381:13391341.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed